{ "schemaVersion": 2, "eyebrow": "Autonomic Medicine", "title": "Orthostatic Hypotension", "summary": "Confirm a reproducible orthostatic blood-pressure fall, identify acute volume, medication, cardiac, or neurogenic drivers, and treat disabling cerebral hypoperfusion while avoiding treatment-induced supine hypertension.", "seoDescription": "Physician approach to orthostatic hypotension: standardized measurement, neurogenic versus non-neurogenic patterns, evaluation, and supine hypertension tradeoffs.", "clinicalQuestion": "How should clinicians confirm orthostatic hypotension, distinguish neurogenic from reversible causes, and manage symptomatic disease safely?", "specialty": "Internal Medicine", "audience": "U.S. physicians and medical trainees", "tags": [ "orthostatic hypotension", "neurogenic orthostatic hypotension", "supine hypertension", "autonomic failure", "postural blood pressure" ], "keyTakeaways": [ "Measure blood pressure after 5 minutes supine and again during the first 3 minutes of standing; orthostatic hypotension is a systolic fall of at least 20 mmHg, or at least 30 mmHg in hypertension, and/or a diastolic fall of at least 10 mmHg. [1][2]", "A blunted orthostatic heart-rate response supports autonomic failure: a delta heart rate/delta systolic blood pressure ratio below 0.5 suggests a neurogenic component, whereas preserved tachycardia favors volume depletion, medication effect, or other non-neurogenic causes. [24]", "Prioritize correction of reversible contributors and symptom/function improvement; pressor therapies can aggravate supine hypertension, which is common in orthostatic hypotension. [9][13]", "Do not misclassify POTS as orthostatic hypotension: POTS requires orthostatic symptoms for at least 3 months plus heart-rate increase of at least 30 bpm within 10 minutes without orthostatic hypotension. [3]" ], "sections": [ { "id": "confirm-and-triage", "eyebrow": "Initial Assessment", "heading": "Confirm orthostatic hypotension and identify immediate hazards", "intro": "Treat instability or an acute systemic cause before pursuing chronic autonomic phenotyping.", "paragraphs": [ "In a patient with syncope, recurrent falls, presyncope, or orthostatic intolerance, first determine whether hypotension is part of an immediately reversible hemodynamic problem. Assess pulse and rhythm, volume status, active bleeding risk, fever or infection, medication exposure, and cardiopulmonary findings; an irregular pulse should prompt caution with automated blood-pressure devices because they can overestimate systolic pressure in atrial fibrillation. [2]", "For diagnostic measurement, obtain supine blood pressure after 5 minutes of rest, then measure during standing through 3 minutes. Orthostatic hypotension is a systolic decrease of at least 20 mmHg, at least 30 mmHg in patients with hypertension, and/or a diastolic decrease of at least 10 mmHg within 3 minutes. Document symptoms at each time point because cerebral hypoperfusion symptoms, syncope, and falls determine clinical significance and treatment urgency. [1][2]", "If bedside measurements are negative despite a compelling positional history, repeat standardized recordings when symptomatic or use head-up tilt assessment to reproduce the blood-pressure and heart-rate response. A single normal set of orthostatic vital signs should not terminate evaluation when episodes are intermittent, medication-related, or volume sensitive. [24]" ], "bullets": [ "Record baseline supine blood pressure and heart rate, standing nadir blood pressure, peak standing heart rate, symptoms, and whether the patient required support or terminated standing. [1][2][24]", "Use manual confirmation when an arrhythmia is suspected rather than relying solely on an automated device. [2]", "Assess fall and syncope consequences promptly; orthostatic hypotension is associated with falls and is an independent mortality marker. [1][7]" ], "subsections": [], "table": { "caption": "Orthostatic vital-sign interpretation that changes the next diagnostic branch. [1][2][3][24]", "columns": [ "Observed response", "Interpretation", "Next action" ], "rows": [ [ "SBP fall >=20 mmHg, or >=30 mmHg with hypertension, and/or DBP fall >=10 mmHg within 3 minutes", "Orthostatic hypotension confirmed. [1][2]", "Classify heart-rate response and search for reversible versus neurogenic causes. [24]" ], [ "Orthostatic BP fall with delta HR/delta SBP ratio <0.5", "Supports a neurogenic component; most neurogenic cases have ratio <0.3. [24]", "Assess for autonomic failure, peripheral neuropathy, or synucleinopathy and consider formal autonomic evaluation when the cause remains uncertain. [1][24]" ], [ "Orthostatic BP fall with delta HR/delta SBP ratio >0.5", "More consistent with intact autonomic compensation and a non-neurogenic contributor, although specificity is imperfect. [24]", "Prioritize volume loss, medication effects, and systemic or cardiac causes. [6][24]" ], [ "HR increase >=30 bpm within 10 minutes of standing or tilt, no orthostatic hypotension, symptoms >=3 months", "Meets hemodynamic and duration elements of POTS when alternative causes of sinus tachycardia are excluded. [3]", "Do not treat as orthostatic hypotension; evaluate and manage as POTS. [3]" ] ] } }, { "id": "etiologic-branching", "eyebrow": "Differential Diagnosis", "heading": "Use heart-rate compensation to separate reversible from neurogenic hypotension", "intro": "The standing heart-rate response is a practical discriminator, but medication effects and rhythm disorders can confound it.", "paragraphs": [ "A preserved tachycardic response to falling blood pressure favors non-neurogenic orthostatic hypotension. Review for reduced effective circulating volume, acute or chronic blood loss, and drugs that impair volume or vascular compensation; non-neurogenic causes can also substantially worsen pre-existing autonomic failure. [6][24] The immediate next step is targeted reversal of the identified driver rather than empiric long-term pressor therapy.", "A blunted heart-rate response—particularly delta heart rate/delta systolic blood pressure below 0.5—supports impaired baroreflex-mediated autonomic compensation. The ratio had reported sensitivity of 91% and specificity of 88% in one study, but later work found specificity as low as 50%; interpret it with the clinical context rather than as a stand-alone diagnosis. [24] Peripheral neuropathy and synucleinopathies are named neurogenic causes, and coexisting supine hypertension increases the likelihood that management will require a pressor-risk tradeoff. [1][9]", "For persistent, unexplained, or progressive suspected neurogenic orthostatic hypotension, escalate phenotyping according to associated neurologic and systemic findings. Available formal evaluations include autonomic nervous system testing, electromyography and nerve-conduction studies, skin biopsy for nerve-fiber density, serum paraneoplastic and autoimmune neuroautoantibody panels, and abdominal fat-pad biopsy. [24] Select these studies to test a specific suspected autonomic neuropathy, paraneoplastic/autoimmune process, or amyloid process rather than ordering a uniform panel." ], "bullets": [ "Interpret a ratio below 0.5 cautiously in patients taking heart-rate-limiting drugs or with a rhythm that prevents an appropriate chronotropic response. [24]", "Screen for coexisting supine hypertension before and during therapy because it is common in orthostatic hypotension and may be worsened by treatment. [9][13]", "When autonomic testing is unavailable, serial standardized orthostatic blood pressure and heart-rate recordings still provide the initial physiologic classification. [1][2][24]" ], "subsections": [], "table": { "caption": "Etiologic branches and targeted escalation in confirmed orthostatic hypotension. [1][6][9][24]", "columns": [ "Branch", "Clinical pattern", "Action" ], "rows": [ [ "Non-neurogenic orthostatic hypotension", "Orthostatic BP fall with preserved heart-rate compensation; volume, medication, or systemic contributors may be present. [6][24]", "Identify and correct the precipitating contributor; reassess orthostatic vitals after the intervention. [6][24]" ], [ "Neurogenic orthostatic hypotension", "Orthostatic BP fall with inadequate heart-rate compensation; peripheral neuropathy and synucleinopathies are representative causes. [1][24]", "Assess neurologic and autonomic features; use autonomic testing and targeted neuropathy, antibody, or tissue evaluation when clinically indicated. [24]" ], [ "Orthostatic hypotension with supine hypertension", "Supine hypertension coexists with symptomatic standing hypoperfusion. [9][13]", "Balance symptom-directed standing BP treatment against worsened supine hypertension; monitor both positions during titration. [9][13]" ] ] } }, { "id": "management-priorities", "eyebrow": "Management", "heading": "Treat functional impairment while minimizing supine hypertension", "intro": "The treatment target is safer upright function, not normalization of a standing blood-pressure value.", "paragraphs": [ "Start by correcting reversible causes and reducing exposures that contribute to orthostatic blood-pressure failure. Recheck supine and standing pressures after each meaningful medication or volume intervention, because treatment response determines whether residual autonomic failure is clinically important. In patients with autonomic failure, non-neurogenic stressors may enhance orthostatic hypotension considerably. [6]", "For severe orthostatic hypotension due to autonomic dysfunction after corrective factors have been excluded and other measures are inadequate, midodrine is a treatment option. [4] Its use requires position-specific blood-pressure surveillance because standard drug treatment can worsen supine hypertension. [8][9] Avoid evaluating benefit only from an office standing measurement; reassess dizziness, presyncope, falls, and ability to remain upright for required activities.", "Droxidopa increases norepinephrine availability and sympathetic tone; fludrocortisone expands volume through sodium and water retention but requires caution for supine hypertension and hypokalemia. Pyridostigmine augments sympathetic ganglionic transmission and may improve standing vascular resistance without significantly affecting supine blood pressure; published reviews describe its benefit as modest. [8][13] Choice should be driven by the patient’s dominant physiologic deficit and supine blood-pressure liability rather than routine combination treatment." ], "bullets": [ "Before initiating or escalating a pressor strategy, document supine hypertension and establish repeat supine and standing blood-pressure monitoring. [9][13]", "Monitor for hypokalemia when fludrocortisone is used. [13]", "Consider pyridostigmine when avoidance of worsened supine blood pressure is a dominant management priority, recognizing that improvement may be limited. [8][13]", "Escalate therapy only when symptoms or functional limitation persist after corrective factors are addressed and the expected upright benefit outweighs supine hypertension risk. [4][9]" ], "subsections": [ { "heading": "Supine hypertension changes the treatment threshold", "paragraphs": [ "Supine hypertension is common in orthostatic hypotension and can be aggravated by therapies intended to raise standing blood pressure. [9][13] The practical consequence is not to withhold all treatment automatically, but to use symptom burden, fall/syncope risk, upright functional impairment, and paired supine-standing measurements to determine whether the benefit of a pressor regimen justifies its nocturnal or supine blood-pressure risk." ], "bullets": [ "Record supine pressure separately from seated and standing values; a satisfactory standing response does not establish safety if supine pressure rises. [9][13]", "Reassess the risk-benefit balance after each medication change because both orthostatic symptoms and supine hypertension can change with titration. [9][13]" ] } ], "table": { "caption": "Medication-selection considerations for neurogenic orthostatic hypotension. [4][8][13]", "columns": [ "Option", "Potential role", "Key tradeoff or monitoring" ], "rows": [ [ "Midodrine", "Option for severe orthostatic hypotension due to autonomic dysfunction when corrective factors are excluded and other treatments are inadequate. [4]", "Standard drug treatment may worsen supine hypertension; monitor blood pressure in supine and standing positions. [8][9]" ], [ "Droxidopa", "Raises norepinephrine availability to improve sympathetic tone and orthostatic symptoms. [13]", "Monitor for supine hypertension during use. [13]" ], [ "Fludrocortisone", "Expands plasma volume through sodium and water retention. [13]", "Use cautiously because of supine hypertension and hypokalemia; monitor potassium and position-specific blood pressure. [13]" ], [ "Pyridostigmine", "May increase vascular resistance during standing and modestly improve orthostatic hypotension. [8][13]", "May avoid significant worsening of supine blood pressure, but benefit may be limited. [8][13]" ] ] } }, { "id": "follow-up-and-escalation", "eyebrow": "Monitoring", "heading": "Reassess by posture, symptoms, and cause-specific progression", "intro": "Monitoring should detect both recurrent upright hypoperfusion and treatment-related supine hypertension.", "paragraphs": [ "At follow-up, repeat standardized supine and standing blood pressure and heart rate, record interval syncope, falls, presyncope, and upright activity limitation, and compare findings with the pre-intervention pattern. Orthostatic hypotension is clinically consequential when cerebral hypoperfusion produces symptoms and can lead to syncope and falls. [1] Persistent symptoms despite correction of reversible contributors should prompt reassessment for neurogenic disease or an unrecognized systemic cause.", "Escalate to formal autonomic and neurologic evaluation when there is a reproducible blunted chronotropic response, progressive symptoms, neuropathic features, or suspicion for synucleinopathy. [1][24] Use electromyography/nerve-conduction studies, skin biopsy, antibody testing, or fat-pad biopsy selectively when their result would establish a treatable or prognostically important etiology. [24]", "Do not make treatment decisions from a single blood-pressure domain. Pressor therapy may improve standing blood pressure while worsening supine hypertension, and the evidence base for many interventions remains heterogeneous with inconsistent symptom and postural-blood-pressure outcomes. [8][9][14] For refractory cases, define success as improved safety and function with an acceptable supine blood-pressure tradeoff." ], "bullets": [ "Repeat orthostatic measurements after correcting a suspected reversible factor or changing a medication regimen. [6][24]", "Track falls and syncope explicitly rather than relying on dizziness alone. [1][7]", "Re-evaluate for POTS only when tachycardia occurs without orthostatic hypotension and the chronicity criteria are met. [3]" ], "subsections": [], "table": { "caption": "Follow-up findings that should change management. [1][3][9][13][24]", "columns": [ "Follow-up finding", "Interpretation", "Next step" ], "rows": [ [ "Symptoms and orthostatic BP fall resolve after reversible-factor correction", "A non-neurogenic contributor was clinically important. [6][24]", "Continue surveillance for recurrence and avoid unnecessary chronic pressor therapy. [6]" ], [ "Persistent BP fall with blunted HR response", "Neurogenic component remains likely. [24]", "Pursue targeted autonomic and neurologic evaluation. [24]" ], [ "Improved standing symptoms but increased supine BP", "Treatment-related supine hypertension tradeoff. [9][13]", "Reassess regimen intensity and monitor both positions before further escalation. [9][13]" ], [ "Orthostatic tachycardia without BP fall", "Orthostatic hypotension is not demonstrated; consider POTS criteria and exclusions. [3]", "Redirect diagnostic evaluation to causes of sinus tachycardia and POTS when duration criteria are met. [3]" ] ] } } ], "faq": [], "references": [ { "number": 1, "title": "Orthostatic hypotension - Symptoms, diagnosis and treatment", "detail": "bestpractice.bmj.com", "url": "https://bestpractice.bmj.com/topics/en-us/972", "authors": "bestpractice.bmj.com", "host": "bestpractice.bmj.com" }, { "number": 2, "title": "Assessment of hypotension - Differential diagnosis of symptoms | BMJ Best Practice", "detail": "bestpractice.bmj.com", "url": "https://bestpractice.bmj.com/topics/en-gb/1196", "authors": "bestpractice.bmj.com", "host": "bestpractice.bmj.com" }, { "number": 3, "title": "Postural orthostatic tachycardia syndrome - Symptoms, diagnosis and treatment | BMJ Best Practice", "detail": "bestpractice.bmj.com", "url": "https://bestpractice.bmj.com/topics/en-gb/3000308", "authors": "bestpractice.bmj.com", "host": "bestpractice.bmj.com" }, { "number": 4, "title": "Midodrine for severe orthostatic hypotension | Drug and Therapeutics Bulletin", "detail": "dtb.bmj.com", "url": "https://dtb.bmj.com/content/54/5/54", "authors": "dtb.bmj.com", "host": "dtb.bmj.com" }, { "number": 5, "title": "Effects of intensive blood pressure treatment on orthostatic ...", "detail": "www.bmj.com", "url": "https://www.bmj.com/content/388/bmj-2024-080507", "authors": "www.bmj.com", "host": "www.bmj.com" }, { "number": 6, "title": "Autonomic diseases: clinical features and laboratory evaluation", "detail": "jnnp.bmj.com", "url": "https://jnnp.bmj.com/content/74/suppl_3/iii31", "authors": "jnnp.bmj.com", "host": "jnnp.bmj.com" }, { "number": 7, "title": "Orthostatic hypotension - Symptoms, diagnosis and treatment | BMJ ...", "detail": "bestpractice.bmj.com", "url": "https://bestpractice.bmj.com/topics/en-gb/972?locale=fa", "authors": "bestpractice.bmj.com", "host": "bestpractice.bmj.com" }, { "number": 8, "title": "Management of neurogenic orthostatic hypotension: an update", "detail": "www.thelancet.com", "url": "https://www.thelancet.com/journals/lancet/article/PIIS1474-4422(08)70088-7/abstract", "authors": "www.thelancet.com", "host": "www.thelancet.com" }, { "number": 9, "title": "Diagnosis and treatment of orthostatic hypotension - The Lancet", "detail": "www.thelancet.com", "url": "https://www.thelancet.com/article/S1474-4422(22)00169-7/fulltext", "authors": "www.thelancet.com", "host": "www.thelancet.com" }, { "number": 10, "title": "Orthostatic Hypotension: a clinical marker for the body-first subtype of patients with Parkinson’s Disease | npj Parkinson's Disease", "detail": "www.nature.com", "url": "https://www.nature.com/articles/s41531-024-00787-y", "authors": "www.nature.com", "host": "www.nature.com" }, { "number": 11, "title": "Consensus statement on the definition of orthostatic hypertension endorsed by the American Autonomic Society and the Japanese Society of Hypertension | Hypertension Research", "detail": "www.nature.com", "url": "https://www.nature.com/articles/s41440-022-01074-0", "authors": "www.nature.com", "host": "www.nature.com" }, { "number": 12, "title": "Orthostatic hypotension without co-existent supine hypertension is associated with impaired cerebral oxygenation: findings from the Irish Longitudinal Study on Ageing (TILDA) | Journal of Human Hypertension", "detail": "www.nature.com", "url": "https://www.nature.com/articles/s41371-026-01125-w", "authors": "www.nature.com", "host": "www.nature.com" }, { "number": 13, "title": "Diabetic neuropathy: cutting-edge research and future ...", "detail": "www.nature.com", "url": "https://www.nature.com/articles/s41392-025-02175-1", "authors": "www.nature.com", "host": "www.nature.com" }, { "number": 14, "title": "Efficacy of treatments for orthostatic hypotension : Age and Ageing", "detail": "journals.lww.com", "url": "https://journals.lww.com/jaanp/fulltext/2013/09000/10.1093/ageing/afs061", "authors": "journals.lww.com", "host": "journals.lww.com" }, { "number": 15, "title": "Review of management strategies for orthostatic hypotension in ...", "detail": "onlinelibrary.wiley.com", "url": "https://onlinelibrary.wiley.com/doi/full/10.1002/jppr.1484", "authors": "onlinelibrary.wiley.com", "host": "onlinelibrary.wiley.com" }, { "number": 16, "title": "Orthostatic Hypotension Associated With Baroreceptor Dysfunction ...", "detail": "onlinelibrary.wiley.com", "url": "https://onlinelibrary.wiley.com/doi/10.1111/jch.12258", "authors": "onlinelibrary.wiley.com", "host": "onlinelibrary.wiley.com" }, { "number": 17, "title": "Characteristics, Management, and Outcomes of Hospitalized ...", "detail": "onlinelibrary.wiley.com", "url": "https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/jch.70118", "authors": "onlinelibrary.wiley.com", "host": "onlinelibrary.wiley.com" }, { "number": 18, "title": "Measurement and management of adult blood pressure in the peri ...", "detail": "associationofanaesthetists-publications.onlinelibrary.wiley.com", "url": "https://associationofanaesthetists-publications.onlinelibrary.wiley.com/doi/10.1111/anae.70082", "authors": "associationofanaesthetists-publications.onlinelibrary.wiley.com", "host": "associationofanaesthetists-publications.onlinelibrary.wiley.com" }, { "number": 19, "title": "Postural orthostatic tachycardia syndrome: clinical presentation ...", "detail": "onlinelibrary.wiley.com", "url": "https://onlinelibrary.wiley.com/doi/10.1111/joim.12852", "authors": "onlinelibrary.wiley.com", "host": "onlinelibrary.wiley.com" }, { "number": 20, "title": "Pyridostigmine for the Management of Neurogenic Orthostatic ...", "detail": "journals.lww.com", "url": "https://journals.lww.com/00001901-202538020-00001", "authors": "journals.lww.com", "host": "journals.lww.com" }, { "number": 21, "title": "Treatment of autonomic dysfunction in Parkinson disease and ...", "detail": "movementdisorders.onlinelibrary.wiley.com", "url": "https://movementdisorders.onlinelibrary.wiley.com/doi/abs/10.1002/mds.27344", "authors": "movementdisorders.onlinelibrary.wiley.com", "host": "movementdisorders.onlinelibrary.wiley.com" }, { "number": 22, "title": "Approach to Cardiovascular Autonomic Dysfunction in Patients with ...", "detail": "movementdisorders.onlinelibrary.wiley.com", "url": "https://movementdisorders.onlinelibrary.wiley.com/doi/10.1002/mdc3.70268", "authors": "movementdisorders.onlinelibrary.wiley.com", "host": "movementdisorders.onlinelibrary.wiley.com" }, { "number": 23, "title": "Orthostatic hypotension and cognitive impairment in ...", "detail": "movementdisorders.onlinelibrary.wiley.com", "url": "https://movementdisorders.onlinelibrary.wiley.com/doi/10.1002/mds.26632", "authors": "movementdisorders.onlinelibrary.wiley.com", "host": "movementdisorders.onlinelibrary.wiley.com" }, { "number": 24, "title": "Evaluation and management of orthostatic hypotension", "detail": "www.ccjm.org", "url": "https://www.ccjm.org/content/89/1/36", "authors": "www.ccjm.org", "host": "www.ccjm.org" } ], "editorialNote": "Prepared from cited clinical literature using Astra's research workflow. Verify recommendations against current guidance and patient-specific factors.", "citations": [ { "number": 1, "title": "Orthostatic hypotension - Symptoms, diagnosis and treatment", "detail": "bestpractice.bmj.com", "url": "https://bestpractice.bmj.com/topics/en-us/972", "authors": "bestpractice.bmj.com", "host": "bestpractice.bmj.com", "snippet": "### References\n\n#### Key articles\n\nJuraschek SP, Cortez MM, Flack JM, et al. Orthostatic hypotension in adults with hypertension: a scientific statement from the American Heart Association. Hypertension. 2024 Mar;81(3):e16-30.Full textAbstract\n\nGibbons CH, Schmidt P, Biaggioni I, et al. The recommen", "score": 0.7640656 }, { "number": 2, "title": "Assessment of hypotension - Differential diagnosis of symptoms | BMJ Best Practice", "detail": "bestpractice.bmj.com", "url": "https://bestpractice.bmj.com/topics/en-gb/1196", "authors": "bestpractice.bmj.com", "host": "bestpractice.bmj.com", "snippet": "(#referencePop6)Freeman R, Wieling W, Axelrod FB, et al. Consensus statement on the definition of orthostatic hypotension, neurally mediated syncope and the postural tachycardia syndrome. Clin Auton Res. 2011 Apr;21(2):69-72.\n\nMost automatic sphygmomanometers overestimate BP in patients with atrial ", "score": 0.56690645 }, { "number": 3, "title": "Postural orthostatic tachycardia syndrome - Symptoms, diagnosis and treatment | BMJ Best Practice", "detail": "bestpractice.bmj.com", "url": "https://bestpractice.bmj.com/topics/en-gb/3000308", "authors": "bestpractice.bmj.com", "host": "bestpractice.bmj.com", "snippet": "Sheldon RS, Grubb BP 2nd, Olshansky B, et al. 2015 Heart Rhythm Society expert consensus statement on the diagnosis and treatment of postural tachycardia syndrome, inappropriate sinus tachycardia, and vasovagal syncope. Heart Rhythm. 2015 Jun;12(6):e41-63.Full textAbstract\n\nShen WK, Sheldon RS, Bend", "score": 0.4342459 }, { "number": 4, "title": "Midodrine for severe orthostatic hypotension | Drug and Therapeutics Bulletin", "detail": "dtb.bmj.com", "url": "https://dtb.bmj.com/content/54/5/54", "authors": "dtb.bmj.com", "host": "dtb.bmj.com", "snippet": "Article Text\n\nDownload PDF\nLoading\n\n## Abstract\n\nMidodrine (Bramox—Brancaster Pharma Limited) was authorised in the UK by the Medicines and Healthcare products Regulatory Agency (MHRA) in March 2015 for “the treatment of severe orthostatic hypotension due to autonomic dysfunction in adults when corr", "score": 0.22197445 }, { "number": 5, "title": "Effects of intensive blood pressure treatment on orthostatic ...", "detail": "www.bmj.com", "url": "https://www.bmj.com/content/388/bmj-2024-080507", "authors": "www.bmj.com", "host": "www.bmj.com", "snippet": "Compared with less intensive treatment, the risk of orthostatic hypertension was lower with more intensive blood pressure treatment (odds ratio", "score": 0.192646 }, { "number": 6, "title": "Autonomic diseases: clinical features and laboratory evaluation", "detail": "jnnp.bmj.com", "url": "https://jnnp.bmj.com/content/74/suppl_3/iii31", "authors": "jnnp.bmj.com", "host": "jnnp.bmj.com", "snippet": "Examples of non-neurogenic causes of orthostatic hypotension. In patients with autonomic failure these may enhance orthostatic hypotension considerably.", "score": 0.45638612 }, { "number": 7, "title": "Orthostatic hypotension - Symptoms, diagnosis and treatment | BMJ ...", "detail": "bestpractice.bmj.com", "url": "https://bestpractice.bmj.com/topics/en-gb/972?locale=fa", "authors": "bestpractice.bmj.com", "host": "bestpractice.bmj.com", "snippet": "Orthostatic hypotension (OH) is an independent predictor of mortality and the cause of significant morbidity associated with falls.", "score": 0.2898343 }, { "number": 8, "title": "Management of neurogenic orthostatic hypotension: an update", "detail": "www.thelancet.com", "url": "https://www.thelancet.com/journals/lancet/article/PIIS1474-4422(08)70088-7/abstract", "authors": "www.thelancet.com", "host": "www.thelancet.com", "snippet": "Standard drug treatment for OH is effective but worsens supine hypertension, whereas pyridostigmine can improve OH slightly but significantly without worsening", "score": 0.6399392 }, { "number": 9, "title": "Diagnosis and treatment of orthostatic hypotension - The Lancet", "detail": "www.thelancet.com", "url": "https://www.thelancet.com/article/S1474-4422(22)00169-7/fulltext", "authors": "www.thelancet.com", "host": "www.thelancet.com", "snippet": "Supine hypertension is common in orthostatic hypotension and can be aggravated by the treatment of orthostatic hypotension, and aiming to avoid it is likely", "score": 0.43755972 }, { "number": 10, "title": "Orthostatic Hypotension: a clinical marker for the body-first subtype of patients with Parkinson’s Disease | npj Parkinson's Disease", "detail": "www.nature.com", "url": "https://www.nature.com/articles/s41531-024-00787-y", "authors": "www.nature.com", "host": "www.nature.com", "snippet": "Article \nPubMed \nPubMed Central \nGoogle Scholar\n\nLahrmann, H. et al. EFNS guidelines on the diagnosis and management of orthostatic hypotension. Eur. J. Neurol. 13, 930–936 (2006).\n\nArticle \nCAS \nPubMed \nGoogle Scholar\n\nFreeman, R. et al. Consensus statement on the definition of orthostatic hypotens", "score": 0.6952351 }, { "number": 11, "title": "Consensus statement on the definition of orthostatic hypertension endorsed by the American Autonomic Society and the Japanese Society of Hypertension | Hypertension Research", "detail": "www.nature.com", "url": "https://www.nature.com/articles/s41440-022-01074-0", "authors": "www.nature.com", "host": "www.nature.com", "snippet": "## References\n\nJordan J, Ricci F, Hoffmann F, Hamrefors V, Fedorowski A. Orthostatic hypertension: critical appraisal of an overlooked condition. Hypertension. 2020;75:1151–8.\n\nArticle \nCAS \nGoogle Scholar\n\nKario K. Orthostatic hypertension–a new haemodynamic cardiovascular risk factor. Nat Rev Neph", "score": 0.6651719 }, { "number": 12, "title": "Orthostatic hypotension without co-existent supine hypertension is associated with impaired cerebral oxygenation: findings from the Irish Longitudinal Study on Ageing (TILDA) | Journal of Human Hypertension", "detail": "www.nature.com", "url": "https://www.nature.com/articles/s41371-026-01125-w", "authors": "www.nature.com", "host": "www.nature.com", "snippet": "Article \nGoogle Scholar\n\nGibbons CH, Schmidt P, Biaggioni I, Frazier-Mills C, Freeman R, Isaacson S, et al. The recommendations of a consensus panel for the screening, diagnosis, and treatment of neurogenic orthostatic hypotension and associated supine hypertension. J Neurol. 2017;264:1567–82.\n\nArti", "score": 0.5760895 }, { "number": 13, "title": "Diabetic neuropathy: cutting-edge research and future ...", "detail": "www.nature.com", "url": "https://www.nature.com/articles/s41392-025-02175-1", "authors": "www.nature.com", "host": "www.nature.com", "snippet": "vasoconstriction to increase peripheral resistance and standing blood pressure;560.\") droxidopa, a norepinephrine precursor that enhances sympathetic tone by increasing norepinephrine levels and improving orthostatic symptoms;561.\") fludrocortisone, a mineralocorticoid that promotes sodium and water", "score": 0.6238588 }, { "number": 14, "title": "Efficacy of treatments for orthostatic hypotension : Age and Ageing", "detail": "journals.lww.com", "url": "https://journals.lww.com/jaanp/fulltext/2013/09000/10.1093/ageing/afs061", "authors": "journals.lww.com", "host": "journals.lww.com", "snippet": "Crossmark: Check for updates\n\n# Efficacy of treatments for orthostatic hypotension\n\n## a systematic review\n\nBackground: orthostatic hypotension (OH) affects up to 30% of adults over 65 and frequently contributes to falls and syncopal episodes. Current guidelines suggest a wide range of treatments, b", "score": 0.7368747 }, { "number": 15, "title": "Review of management strategies for orthostatic hypotension in ...", "detail": "onlinelibrary.wiley.com", "url": "https://onlinelibrary.wiley.com/doi/full/10.1002/jppr.1484", "authors": "onlinelibrary.wiley.com", "host": "onlinelibrary.wiley.com", "snippet": "In this review we present the current evidence for existing and emerging treatments for OH and address the management of supine hypertension", "score": 0.4400126 }, { "number": 16, "title": "Orthostatic Hypotension Associated With Baroreceptor Dysfunction ...", "detail": "onlinelibrary.wiley.com", "url": "https://onlinelibrary.wiley.com/doi/10.1111/jch.12258", "authors": "onlinelibrary.wiley.com", "host": "onlinelibrary.wiley.com", "snippet": "The primary target of treating orthostatic hypotension is to improve the patient's functional status by ameliorating symptoms, reducing the risk", "score": 0.32533884 }, { "number": 17, "title": "Characteristics, Management, and Outcomes of Hospitalized ...", "detail": "onlinelibrary.wiley.com", "url": "https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/jch.70118", "authors": "onlinelibrary.wiley.com", "host": "onlinelibrary.wiley.com", "snippet": "Orthostatic hypotension (OH) is a common inpatient condition associated with falls, syncope, and mortality. However, standardized approaches for", "score": 0.29936165 }, { "number": 18, "title": "Measurement and management of adult blood pressure in the peri ...", "detail": "associationofanaesthetists-publications.onlinelibrary.wiley.com", "url": "https://associationofanaesthetists-publications.onlinelibrary.wiley.com/doi/10.1111/anae.70082", "authors": "associationofanaesthetists-publications.onlinelibrary.wiley.com", "host": "associationofanaesthetists-publications.onlinelibrary.wiley.com", "snippet": "A thorough postural hypotension assessment should ideally be undertaken with blood pressure measured in the supine position and within 3 min (", "score": 0.19273713 }, { "number": 19, "title": "Postural orthostatic tachycardia syndrome: clinical presentation ...", "detail": "onlinelibrary.wiley.com", "url": "https://onlinelibrary.wiley.com/doi/10.1111/joim.12852", "authors": "onlinelibrary.wiley.com", "host": "onlinelibrary.wiley.com", "snippet": "After the diagnosis has been established, patient should be thoroughly educated about non-pharmacological measures alleviating the symptoms.", "score": 0.18055448 }, { "number": 20, "title": "Pyridostigmine for the Management of Neurogenic Orthostatic ...", "detail": "journals.lww.com", "url": "https://journals.lww.com/00001901-202538020-00001", "authors": "journals.lww.com", "host": "journals.lww.com", "snippet": "Pyridostigmine is hypothesized to improve neurogenic orthostatic hypotension (nOH) symptoms without causing or exacerbating supine hypertension.", "score": 0.098295696 }, { "number": 21, "title": "Treatment of autonomic dysfunction in Parkinson disease and ...", "detail": "movementdisorders.onlinelibrary.wiley.com", "url": "https://movementdisorders.onlinelibrary.wiley.com/doi/abs/10.1002/mds.27344", "authors": "movementdisorders.onlinelibrary.wiley.com", "host": "movementdisorders.onlinelibrary.wiley.com", "snippet": "by JA Palma · 2018 · Cited by 315 — Defining successful treatment of neurogenic orthostatic hypotension with droxidopa in a patient with multiple system atrophy.", "score": 0.6383174 }, { "number": 22, "title": "Approach to Cardiovascular Autonomic Dysfunction in Patients with ...", "detail": "movementdisorders.onlinelibrary.wiley.com", "url": "https://movementdisorders.onlinelibrary.wiley.com/doi/10.1002/mdc3.70268", "authors": "movementdisorders.onlinelibrary.wiley.com", "host": "movementdisorders.onlinelibrary.wiley.com", "snippet": "Association between orthostatic hypotension and dementia in patients with Parkinson disease and multiple system atrophy. Neurology 2023; 100", "score": 0.5996498 }, { "number": 23, "title": "Orthostatic hypotension and cognitive impairment in ...", "detail": "movementdisorders.onlinelibrary.wiley.com", "url": "https://movementdisorders.onlinelibrary.wiley.com/doi/10.1002/mds.26632", "authors": "movementdisorders.onlinelibrary.wiley.com", "host": "movementdisorders.onlinelibrary.wiley.com", "snippet": "Apr 19, 2016 — Orthostatic hypotension and cognitive impairment are common in Parkinson's disease (PD) and significantly impair quality of life.", "score": 0.34488514 }, { "number": 24, "title": "Evaluation and management of orthostatic hypotension", "detail": "www.ccjm.org", "url": "https://www.ccjm.org/content/89/1/36", "authors": "www.ccjm.org", "host": "www.ccjm.org", "snippet": "Diagnostic approach to orthostatic hypotension. a Delta HR/delta SBP ratio is the ratio of the change in heart rate divided by the change in systolic blood pressure with standing or head-up tilt. Most patients with neurogenic orthostatic hypotension have a ratio below 0.3. Most patients with a norma", "score": 0.6826801 } ], "publishedAt": "2026-09-15T22:52:30.844121+00:00", "updatedAt": "2026-09-15T22:52:30.844121+00:00", "readingMinutes": 6, "slug": "orthostatic-hypotension" }